Brucellosis

Pappas G, Papadimitriou P, Akritidis N, et al. The new global map of human brucellosis. Lancet Infect Dis. 2006 Feb;6(2):91-9. Abstract

Dean AS, Crump L, Greter H, et al. Global burden of human brucellosis: a systematic review of disease frequency. PLoS Negl Trop Dis. 2012;6(10):e1865.Full text  Abstract

Dean AS, Crump L, Greter H, et al. Clinical manifestations of human brucellosis: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2012;6(12):e1929.Full text  Abstract

Franco MP, Mulder M, Gilman RH, et al. Human brucellosis. Lancet Infect Dis. 2007 Dec;7(12):775-86. Abstract

Al Dahouk S, Sprague LD, Neubauer H. New developments in the diagnostic procedures for zoonotic brucellosis in humans. Rev Sci Tech. 2013 Apr;32(1):177-88. Abstract

Skalsky K, Yahav D, Bishara J, et al. Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials. BMJ. 2008 Mar 29;336(7646):701-4.Full text  Abstract

Yousefi-Nooraie R, Mortaz-Hejri S, Mehrani M, et al. Antibiotics for treating human brucellosis. Cochrane Database Syst Rev. 2012 Oct 17;10:CD007179.Full text  Abstract

1. Madkour MM. Madkour's brucellosis. 2nd ed. New York, NY: Springer-Verlag; 2001.

2. Pappas G, Akritidis N, Bosilkovski M, et al. Brucellosis. N Engl J Med. 2005 Jun 2;352(22):2325-36. Abstract

3. Hasanjani Roushan MR, Moherez M, Smailnejad Gangi SM, et al. Epidemiological features and clinical manifestations in 469 adult patients with brucellosis in Babol, Northern Iran. Epidemiol Infect. 2004 Dec;132(6):1109-14. Abstract

4. Andriopoulos P, Tsironi M, Deftereos S, et al. Acute brucellosis: presentation, diagnosis, and treatment of 144 cases. Int J Infect Dis. 2007 Jan;11(1):52-7.Full text  Abstract

5. Pappas G, Papadimitriou P, Akritidis N, et al. The new global map of human brucellosis. Lancet Infect Dis. 2006 Feb;6(2):91-9. Abstract

6. Mor SM, Wiethoelter AK, Massey PD, et al. Pigs, pooches and pasteurisation: the changing face of brucellosis in Australia. Aust J Gen Pract. 2018 Mar;47(3):99-103.Full text  Abstract

7. Young EJ. An overview of human brucellosis. Clin Infect Dis. 1995 Aug;21(2):283-9. Abstract

8. Pappas G. The changing Brucella ecology: novel reservoirs, new threats. Int J Antimicrob Agents. 2010 Nov;36(suppl 1):S8-11.Full text  Abstract

9. Mantur BG, Amarnath SK, Shinde RS. Review of clinical and laboratory features of human brucellosis. Indian J Med Microbiol. 2007 Jul;25(3):188-202. Abstract

10. Gwida M, Al Dahouk S, Melzer F, et al. Brucellosis - regionally emerging zoonotic disease? Croat Med J. 2010 Aug;51(4):289-95.Full text  Abstract

11. Campbell JI, Lan NPH, Phuong PM, et al. Human Brucella melitensis infections in southern Vietnam. Clin Microbiol Infect. 2017 Nov;23(11):788-90.Full text  Abstract

12. Guerrier G, Daronat JM, Morisse L, et al. Epidemiological and clinical aspects of human Brucella suis infection in Polynesia. Epidemiol Infect. 2011 Oct;139(10):1621-5. Abstract

13. Ekpanyaskul C, Santiwattanakul S, Tantisiriwat W, et al. Factors associated with seropositive antibodies to Brucella melitensis in the Nakhon Nayok, Thailand. J Med Assoc Thai. 2012 Dec;95(suppl 12):S40-6. Abstract

14. Lewis JM, Folb J, Kalra S, et al. Brucella melitensis prosthetic joint infection in a traveller returning to the UK from Thailand: case report and review of the literature. Travel Med Infect Dis. 2016 Sep - Oct;14(5):444-50.Full text  Abstract

15. Godfroid J, Cloeckaert A, Liautard JP, et al. From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet Res. 2005 May-Jun;36(3):313-26.Full text  Abstract

16. Zinsstag J, Schelling S, Wyss K, et al. Potential of cooperation between human and animal health to strengthen health systems. Lancet. 2005 Dec 17;366(9503):2142-5. Abstract

17. Kunda J, Fitzpatrick J, Kazwala R, et al. Health-seeking behaviour of human brucellosis cases in rural Tanzania. BMC Public Health. 2007 Nov 3;7:315.Full text  Abstract

18. Dean AS, Crump L, Greter H, et al. Global burden of human brucellosis: a systematic review of disease frequency. PLoS Negl Trop Dis. 2012;6(10):e1865.Full text  Abstract

19. Almuneef MA, Memish ZA, Balkhy HH, et al. Importance of screening household members of acute brucellosis cases in endemic areas. Epidemiol Infect. 2004 Jun;132(3):533-40. Abstract

20. Mendoza-Núñez M, Mulder M, Franco MP, et al. Brucellosis in household members of Brucella patients residing in a large urban setting in Peru. Am J Trop Med Hyg. 2008 Apr;78(4):595-8 Abstract

21. Memish ZA, Balkhy HH. Brucellosis and international travel. J Travel Med. 2004 Jan-Feb;11(1):49-55. Abstract

22. Dahouk SA, Neubauer H, Hensel A, et al. Changing epidemiology of human brucellosis, Germany, 1962-2005. Emerg Infect Dis. 2007 Dec;13(12):1895-900.Full text  Abstract

23. Australian Government Department of Health. National Notifiable Diseases Surveillance System. Notifications of a selected disease by month and year, 1991 to present. Brucellosis. March 2019 [internet publication].Full text

24. Centers for Disease Control and Prevention. National notifiable infectious diseases and conditions: United States. Table 2d. 2019 [internet publication].Full text

25. Centers for Disease Control and Prevention. CDC and Texas health officials warn about illness linked to raw milk from Texas dairy. September 2017 [internet publication].Full text

26. Cossaboom CM, Kharod GA, Salzer JS, et al. Notes from the field: brucella abortus vaccine strain RB51 infection and exposures associated with raw milk consumption - Wise County, Texas, 2017. MMWR Morb Mortal Wkly Rep. 2018 Mar 9;67(9):286.Full text  Abstract

27. Centers for Disease Control and Prevention. People in four states may be drinking contaminated raw milk. November 2017 [internet publication].Full text

28. Centers for Disease Control and Prevention. Health Alert Network (HAN). Third case of rifampin/penicillin-resistant strain of RB51 brucella from consuming raw milk. January 2019 [internet publication].Full text

29. Pike RM. Laboratory-associated infections: summary and analysis of 3921 cases. Health Lab Sci. 1976 Apr;13(2):105-14. Abstract

30. Harding AL, Byers KB. Epidemiology of laboratory-associated infections. In: Fleming DO, Hunt DL, eds. Biological safety: principles and practices. 3rd ed. Washington, DC: ASM Press; 2000:35-36.

31. Ergonul O, Celikbas A, Tezeren D, et al. Analysis of risk factors for laboratory-acquired Brucella infections. J Hosp Infect. 2004 Mar;56(3):223-7. Abstract

32. Yagupsky P, Baron EJ. Laboratory exposures to brucellae and implications for bioterrorism. Emerg Infect Dis. 2005 Aug;11(8):1180-5. Abstract

33. Bouza E, Sanchez-Carrillo C, Hernangomez S, et al. Laboratory-acquired brucellosis: a Spanish national survey. J Hosp Infect. 2005 Sep;61(1):80-3. Abstract

34. Centers for Disease Control and Prevention (CDC). Laboratory-acquired brucellosis - Indiana and Minnesota, 2006. MMWR Morb Mortal Wkly Rep. 2008 Jan 18;57(2):39-42.Full text  Abstract

35. Reddy S, Manuel R, Sheridan E, et al. Brucellosis in the United Kingdom - a risk to laboratory workers? Recommendations for prevention and management of laboratory exposure. J Clin Pathol. 2010 Jan;63(1):90-2. Abstract

36. Knudsen A, Kronborg G, Dahl Knudsen J, et al. Laboratory exposure to Brucella melitensis in Denmark: a prospective study. J Hosp Infect. 2013 Nov;85(3):237-9. Abstract

37. Traxler RM, Lehman MW, Bosserman EA, et al. A literature review of laboratory-acquired brucellosis. J Clin Microbiol. 2013 Sep;51(9):3055-62.Full text  Abstract

38. Beeching NJ. Brucellosis. In Fauci AS, Braunwald E, Kasper DL, et al., eds. Harrison’s principles of internal medicine. 20th ed. New York, NY: McGraw-Hill; 2018:1192-6.

39. Beeching NJ, Madkour MM. Brucellosis. In: Farrar J, Hotez P, Junghanss T, et al, eds. Manson’s tropical diseases. 23rd ed. London: Elsevier; 2013:371-378, 378.e1.

40. De BK, Stauffer L, Koylass MS, et al. Novel Brucella strain (BO1) associated with a prosthetic breast implant infection. J Clin Microbiol. 2008 Jan;46(1):43-9.Full text  Abstract

41. Scholz HC, Nöckler K, Göllner C, et al. Brucella inopinata sp. nov., isolated from a breast implant infection. Int J Syst Evol Microbiol. 2010 Apr;60(Pt 4):801-8.Full text  Abstract

42. Jiménez de Bagüés MP, Iturralde M, Arias MA, et al. The new strains Brucella inopinata BO1 and Brucella species 83-210 behave biologically like classic infectious Brucella species and cause death in murine models of infection. J Infect Dis. 2014 Aug 1;210(3):467-72.Full text  Abstract

43. Sabbaghian H. Fresh white cheese as a cause of Brucella infection. Public Health. 1975 May;89(4):165-9. Abstract

44. Entessar F, Ardalan A. Brucella. Geneva: World Health Organization; 1964.

45. Beeching NJ, Erdem H. Brucellosis. In: Cohen J, Powderly WG, Opal SM, eds. Infectious diseases. 4th ed. London: Elsevier Science; 2016:1098-1101.

46. Langer AJ, Ayers T, Grass J, et al. Nonpasteurized dairy products, disease outbreaks, and state laws - United States, 1993-2006. Emerg Infect Dis. 2012 Mar;18(3):385-91.Full text  Abstract

47. Claeys WL, Cardoen S, Daube G, et al. Raw or heated cow milk consumption: review of risks and benefits. Food Control. 2013;31:251-62.

48. Guihot A, Bossi P, Bricaire F. Bioterrorism with brucellosis [in French]. Presse Med. 2004 Jan 31;33(2):119-22. Abstract

49. Flynn MP. Human clinical bovine-type brucellosis not derived from milk. Public Health. 1983 May;97(3):149-57. Abstract

50. Kaufmann AF, Fox MD, Boyce JM, et al. Airborne spread of brucellosis. Ann N Y Acad Sci. 1980;353:105-14. Abstract

51. Mantur BG, Mangalgi SS, Mulimani M. Brucella melitensis - a sexually transmissible agent? Lancet. 1996 Jun 22;347(9017):1763. Abstract

52. Gross A, Terraza A, Ouahrani-Bettache S, et al. In vitro Brucella suis infection prevents the programmed cell death of human monocytic cells. Infect immun. 2000;68:342-351.Full text  Abstract

53. de Figueiredo P, Ficht TA, Rice-Ficht A, et al. Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions. Am J Pathol. 2015;185:1505-1517.Full text  Abstract

54. Khan MY, Mah WM, Memish ZA. Brucellosis in pregnant women. Clin Infect Dis. 2001 Apr 15;32(8):1172-7.Full text  Abstract

55. Kurdoglu M, Adali E, Kurdoglu Z, et al. Brucellosis in pregnancy: a 6-year clinical analysis. Arch Gynecol Obstet. 2010 Feb;281(2):201-6. Abstract

56. Paul J, Gilks C, Batchelor B, et al. Serologic responses to brucellosis in HIV-seropositive patients. Trans R Soc Trop Med Hyg. 1995;89:228-230. Abstract

57. Moreno S, Ariza J, Espinosa FJ, et al. Brucellosis in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis. 1998;17:319-326. Abstract

58. Georghiou PR, Young EJ. Prolonged incubation in brucellosis. Lancet. 1991;337:1543. Abstract

59. Centers for Disease Control and Prevention. Brucellosis reference guide: exposures, testing and prevention. February 2017 [internet publication].Full text

60. Syrjamaki C, Migliazzo A, Yarbrough JW, et al. Brucella abortus endocarditis following ingestion of cow's blood. Nebr Med J. 1984 May;69(5):141-2. Abstract

61. Greenfield RA, Drevets DA, Machado LJ, et al. Bacterial pathogens as biological weapons and agents of bioterrorism. Am J Med Sci. 2002 Jun;323(6):299-315. Abstract

62. Pappas G, Panagopoulou P, Christou L, et al. Brucella as a biological weapon. Cell Mol Life Sci. 2006 Oct;63(19-20):2229-36. Abstract

63. Williams B. Brucellosis. Practitioner. 1982 Sep;226(1371):1507-17. Abstract

64. Gerada A, Beeching NJ. Brucellosis and travel. Travel Med Infect Dis. 2016 May-Jun;14(3):180-1. Abstract

65. Norman FF, Monge-Maillo B, Chamorro-Tojeiro S, et al. Imported brucellosis: a case series and literature review. Travel Med Infect Dis. 2016 May-Jun;14(3):182-99. Abstract

66. Bosilkovski M, Rodriguez-Morales AJ. Brucellosis and its particularities in children travelers. Recent Pat Antiinfect Drug Discov. 2014;9(3):164-72. Abstract

67. Wyatt HV. Brucella melitensis can be transmitted sexually. Lancet. 11996 Aug 31;348(9027):615. [Erratum in: Lancet 1996 Oct 5;348(9032):970.] Abstract

68. Economidou J, Kalafatas P, Vatopolou D, et al. Brucellosis in two thalassaemic patients infected by blood transfusions from the same donor. Acta Haematol. 1976;55(4):244-9. Abstract

69. Martinez-Canseco J, Hernandez-Ramos I, Macias-Hernandez AE, et al. Unjustified disposal of transfusion blood because of antibodies against Brucella [in Spanish]. Rev Invest Clin. 1996 Jul-Aug;48(4):297-300. Abstract

70. World Health Organization. Brucellosis in humans and animals. 2006 [internet publication].Full text

71. Luzzi GA, Brindle R, Sockett PN, et al. Brucellosis: imported and laboratory-acquired cases, and an overview of treatment trials. Trans R Soc Trop Med Hyg. 1993 Mar-Apr;87(2):138-41. Abstract

72. Centers for Disease Control and Prevention. Brucellosis. Exposure to RB51 through raw milk or milk products: how to reduce risk of infection. September 2017 [internet publication].Full text

73. Robichaud S, Libman M, Behr M, et al. Prevention of laboratory-acquired brucellosis. Clin Infect Dis. 2004 Jun 15;38(12):e119-22.Full text  Abstract

74. Centers for Disease Control and Prevention. Brucellosis: hunters risks. January 2016 [internet publication].Full text

75. Mantur BG, Akki AS, Mangalgi SS, et al. Childhood brucellosis - a microbiological, epidemiological and clinical study. J Trop Pediatr. 2004 Jun;50(3):153-7. Abstract

76. Barroso García P, Rodriguez-Contreras Pelayo R, Gil Extremera B, et al. Study of 1,595 brucellosis cases in the Almeria province (1972-1998) based on epidemiological data from disease reporting [in Spanish]. Rev Clin Esp. 2002 Nov;202(11):577-82. Abstract

77. Dean AS, Crump L, Greter H, et al. Clinical manifestations of human brucellosis: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2012;6(12):e1929.Full text  Abstract

78. Franco MP, Mulder M, Gilman RH, et al. Human brucellosis. Lancet Infect Dis. 2007 Dec;7(12):775-86. Abstract

79. Colomenero JD, Reguera JM, Martos F, et al. Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine (Baltimore). 1996 Jul;75(4):195-211. [Erratum in: Medicine (Baltimore) 1997 Mar;76(2):139.] Abstract

80. Uddin MJ, Sanyal SC, Mustafa AS, et al. The role of aggressive medical therapy along with early surgical intervention in the cure of Brucella endocarditis. Ann Thorac Cardiovasc Surg. 1998 Aug;4(4):209-13. Abstract

81. Pappas G, Bosilkovski M, Akritidis N, et al. Brucellosis and the respiratory system. Clin Infect Dis. 2003 Oct 1;37(7):e95-9.Full text  Abstract

82. Erdem H, Inan A, Elaldi N, et al. Respiratory system involvement in brucellosis: the results of the Kardelen study. Chest. 2014 Jan;145(1):87-94.Full text  Abstract

83. Milionis H, Christou L, Elisaf M. Cutaneous manifestations in brucellosis: case report and review of the literature. Infection. 2000 Mar-Apr;28(2):124-6. Abstract

84. Al Dahouk S, Sprague LD, Neubauer H. New developments in the diagnostic procedures for zoonotic brucellosis in humans. Rev Sci Tech. 2013 Apr;32(1):177-88. Abstract

85. Gotuzzo E, Carrilo C, Guerra J, et al. An evaluation of diagnostic methods for brucellosis - the value of bone marrow culture. J Infect Dis. 1986 Jan;153(1):122-5. Abstract

86. Doganay M, Aygen B. Human brucellosis: an overview. Int J Infect Dis. 2003;7:173-82.

87. Yagupsky P. Detection of brucellae in blood cultures. J Clin Microbiol. 1999 Nov;37(11):3437-42.Full text  Abstract

88. Gómez MC, Nieto JA, Rosa C, et al. Evaluation of seven tests for diagnosis of human brucellosis in an area where the disease is endemic. Clin Vaccine Immunol. 2008 Jun;15(6):1031-3.Full text  Abstract

89. Ruiz-Mesa JD, Sanchez-Gonzalez J, Reguera JM, et al. Rose Bengal test: diagnostic yield and use for the rapid diagnosis of human brucellosis in emergency departments in endemic areas. Clin Microbiol Infect. 2005 Mar;11(3):221-5. Abstract

90. Araj GF, Lulu AR, Mustafa MY, et al. Evaluation of ELISA in the diagnosis of acute and chronic brucellosis in human beings. J Hyg (Lond). 1986 Dec;97(3):457-69. Abstract

91. Abdoel TH, Smits HL. Rapid latex agglutination test for the serodiagnosis of human brucellosis. Diagn Microbiol Infect Dis. 2007 Feb;57(2):123-8. Abstract

92. Nielson K, Smith P, Widdison J, et al. Serological relationship between cattle exposed to Brucella abortus, Yersinia enterocolitica O:9 and Escherichia coli O157:H7. Vet Microbiol. 2004 May 20;100(1-2):25-30. Abstract

93. Ariza J, Pellicer T, Pallares R, et al. Specific antibody profile in human brucellosis. Clin Infect Dis. 1992 Jan;14(1):131-40. Abstract

94. Lucero NE, Escobar GI, Ayala SM, et al. Diagnosis of human brucellosis caused by Brucella canis. J Med Microbiol. 2005 May;54(Pt 5):457-61.Full text  Abstract

95. Ashford DA, di Pietra J, Lingappa J, et al. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51. Vaccine. 2004 Sep 3;22(25-26):3435-9. Abstract

96. Queipo-Ortuño MI, Morata P, Ocón P, et al. Rapid diagnosis of human brucellosis by peripheral-blood PCR assay. J Clin Microbiol. 1997 Nov;35(11):2927-30.Full text  Abstract

97. Mitka S, Anetakis C, Souliou E, et al. Evaluation of different PCR assays for early detection of acute and relapsing brucellosis in humans in comparison with conventional methods. J Clin Microbiol. 2007 Apr;45(4):1211-8.Full text  Abstract

98. Vrioni G, Pappas G, Priavali E, et al. An eternal microbe: Brucella DNA load persists for years after clinical cure. Clin Infect Dis. 2008 Jun 15;46(12):e131-6.Full text  Abstract

99. Lista F, Reubsaet FA, De Santis R, et al. Reliable identification at the species level of Brucella isolates with MALDI-TOF-MS. BMC Microbiol. 2011 Dec 23;11:267.Full text  Abstract

100. Ferreira L, Vega Castaño S, Sánchez-Juanes F, et al. Identification of Brucella by MALDI-TOF mass spectrometry: fast and reliable identification from agar plates and blood cultures. PLoS One. 2010 Dec 6;5(12):e14235.Full text  Abstract

101. Karger A, Melzer F, Timke M, et al. Interlaboratory comparison of intact-cell matrix-assisted laser desorption ionization-time of flight mass spectrometry results for identification and differentiation of Brucella spp. J Clin Microbiol. 2013 Sep;51(9):3123-6.Full text  Abstract

102. Araj GF, Lulu AR, Khateeb MI, et al. ELISA versus routine tests in the diagnosis of patients with systemic and neurobrucellosis. APMIS. 1988 Feb;96(2):171-6. Abstract

103. Erdem H, Kilic S, Sener B, et al. Diagnosis of chronic brucellar meningitis and meningoencephalitis: the results of the Istanbul-2 study. Clin Microbiol Infect. 2013 Feb;19(2):E80-6. Abstract

104. Yagupsky P, Peled N. Use of the Isolator 1.5 microbial tube for detection of Brucella melitensis in synovial fluid. J Clin Microbiol. 2002 Oct;40(10):3878.Full text  Abstract

105. Kokoglu OF, Hosoglu S, Geyik MF, et al. Clinical and laboratory features of brucellosis in two university hospitals in Southeast Turkey. Trop Doct. 2006 Jan;36(1):49-51. Abstract

106. Troy SB, Rickman LS, Davis CE. Brucellosis in San Diego: epidemiology and species-related differences in acute clinical presentations. Medicine (Baltimore). 2005 May;84(3):174-87. Abstract

107. Al-Shahed MS, Sharif HS, Haddad MC, et al. Imaging features of musculoskeletal brucellosis. Radiographics. 1994 Mar;14(2):333-48. Abstract

108. Pourbagher A, Pourbagher MA, Savas L, et al. Epidemiologic, clinical, and imaging findings in brucellosis patients with osteoarticular involvement. AJR Am J Roentgenol. 2006 Oct;187(4):873-80.Full text  Abstract

109. Erdem H, Elaldi N, Ak O, et al. Genitourinary brucellosis: results of a multicentric study. Clin Microbiol Infect. 2014 Nov;20(11):O847-53.Full text  Abstract

110. Centers for Disease Control and Prevention. Brucellosis (Brucella spp.) 2010 case definition. 2010 [internet publication].Full text

111. Public Health England. Brucella: laboratory and clinical services. December 2020 [internet publication].Full text

112. Rusnak JM, Kortepeter MG, Aldis J, et al. Experience in the medical management of potential laboratory exposures to agents of bioterrorism on the basis of risk assessment at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID). J Occup Environ Med. 2004 Aug;46(8):801-11. Abstract

113. Corbel MJ. Brucellosis: an overview. Emerg Infect Dis. 1997 Apr-Jun;3(2):213-21.Full text  Abstract

114. Brown CE, Beeching NJ, Cooke RP. Laboratory acquired brucellosis - a review of published reports 1950-2007. Posters, 18th ECCMID, abstract P1852. Clin Microbiol Infect. 2008;14(suppl 7):S542.Full text

115. Negrón ME, Tiller R, Kharod G, Brucellosis. In: Brunette, GW, Nemhauser JB, eds. CDC Yellow Book 2020: health information for international travel. Oxford: Oxford University Press; 2019.Full text

116. Washington State Department of Health. Brucellosis. Dec 2019 [internet publication].Full text

117. Ariza J, Bosilkovski M, Cascio A, et al. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med. 2007 Dec;4(12):e317.Full text  Abstract

118. Skalsky K, Yahav D, Bishara J, et al. Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials. BMJ. 2008 Mar 29;336(7646):701-4.Full text  Abstract

119. Solís García del Pozo J, Solera J. Systematic review and meta-analysis of randomized clinical trials in the treatment of human brucellosis. PLoS One. 2012;7(2):e32090.Full text  Abstract

120. Yousefi-Nooraie R, Mortaz-Hejri S, Mehrani M, et al. Antibiotics for treating human brucellosis. Cochrane Database Syst Rev. 2012 Oct 17;10:CD007179.Full text  Abstract

121. Hashemi SH, Gachkar L, Keramat F, et al. Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial. Int J Infect Dis. 2012 Apr;16(4):e247-51. Abstract

122. Pappas G, Christou L, Akritidis N, et al. Quinolones for brucellosis: treating old diseases with new drugs. Clin Microbiol Infect. 2006 Sep;12(9):823-5. Abstract

123. Bosilkovski M, Kirova V, Grozdanovski K, et al. Doxycycline-rifampin versus doxycycline-rifampin-gentamicin in treatment of human brucellosis. Trop Doct. 2012 Jan;42(1):13-7. Abstract

124. Vrioni G, Bourdakis A, Pappas G, et al. Administration of a triple versus a standard double antimicrobial regimen for human brucellosis more efficiently eliminates bacterial DNA load. Antimicrob Agents Chemother. 2014 Dec;58(12):7541-4.Full text  Abstract

125. Keshtkar-Jahromi M, Razavi SM, Gholamin S, et al. Medical versus medical and surgical treatment for brucella endocarditis. Ann Thorac Surg. 2012 Dec;94(6):2141-6. Abstract

126. Pappas G, Akritidis N, Christou L. Treatment of neurobrucellosis: what is known and what remains to be answered. Expert Rev Anti Infect Ther. 2007 Dec;5(6):983-90. Abstract

127. Erdem H, Ulu-Kilic A, Kilic S, et al. Efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul study. Antimicrob Agents Chemother. 2012 Mar;56(3):1523-8.Full text  Abstract

128. Ulu-Kilic A, Karakas A, Erdem H, et al. Update on treatment options for spinal brucellosis. Clin Microbiol Infect. 2014 Feb;20(2):O75-82. Abstract

129. Beeching NJ. Brucellosis. In Fauci AS, Braunwald E, Kasper DL, et al., eds. Harrison’s principles of internal medicine. 20th ed. New York, NY: McGraw-Hill; 2018:1192-6.

130. Beeching NJ, Madkour MM. Brucellosis. In: Farrar J, Hotez P, Junghanss T, et al, eds. Manson’s tropical diseases. 23rd ed. London: Elsevier; 2013:371-378, 378.e1.

131. Madkour MM. Madkour's brucellosis. 2nd ed. New York, NY: Springer-Verlag; 2001.

132. Centers for Disease Control and Prevention (CDC). Suspected brucellosis case prompts investigation of possible bioterrorism-related activity - New Hampshire and Massachusetts, 1999. MMWR Morb Mortal Weekly Rep. 2000;49:509-512.Full text  Abstract

133. Public Health England. Management of laboratory exposure to Brucella species: assessing exposure and individual assessment flowchartFull text